Browsing: drug
Scientists in the United States, especially those in the biomedical fields, are increasingly leaving the world of academia for better-paying…
By Patrick Wingrove (Reuters) – Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company’s revenue growth per…
Robert Mazur tells the full story of his time as a government agent investigating drug-money laundering. Mazur went undercover for…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close…
A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on…
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung…
The blockbuster case at the Supreme Court that could make it harder for millions of Americans to access the abortion…
Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to…
NEW YORK – Immunic, Inc. (NASDAQ: NASDAQ:), a biotechnology firm focused on chronic inflammatory and autoimmune diseases, has been granted…